Hyderabad (Telangana) [India], September 6 (ANI): Hetero announced on Monday that the Drug Controller General of India (DCGI) has approved Emergency Use Authorization (EUA) for its generic version of Tocilizumab in India for the treatment of COVID-19 in hospitalised adults.
New Delhi [India], September 2 (ANI): The Drug Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 & 3 clinical trials for its anti-COVID shots called Corbevax on children between 5 and 18 years of age with certain
Pune (Maharashtra) [India], August 27 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI) for its third biosimilar drug 'Denosumab', indicated for the treatment of osteoporosis in adults.
Pune (Maharashtra) [India], August 20 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI) for its second biosimilar drug "Romiplostim", indicated for the treatment of chronic Immune Thrombocyt
New Delhi [India], July 29 (ANI): The Delhi High Court on Thursday pulled up the state's Drug Controller for targeting leaders like AAP MLAs and for initiating prosecution against them on allegations of hoarding oxygen and said that if it is taking action against them who were having oxygen
New Delhi [India], July 17 (ANI): Delhi's Drug Controller Department told the Delhi High Court that it has initiated proceedings against Bharatiya Janata Party leader and Member of Parliament Gautam Gambhir's foundation, and Aam Aadmi Party legislators Praveen Kumar and Imran Hussain for
New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and Johnson twice in writing to apply for emergency use authorisation for their COVID-19 vaccine so that application is processed well in time but pharma companies have not applied for
New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its DNA vaccine ZyCoV-D against coronavirus disease and stated that they expect to produce
New Delhi [India], June 4 (ANI): The Drug Controller General of India (DCGI) on Friday granted the approval to the Serum Institute of India (SII) for the initial manufacture of the Russian COVID-19 vaccine Sputnik V for testing, examination, and analysis purposes with certain conditions at i
New Delhi [India], June 4 (ANI): Centre through an affidavit on Friday informed the Delhi High Court that on May 12, 2021, the Drug Controller General of India (DCGI) has permitted Bharat Biotech to conduct clinical trials on healthy volunteers between 2 years to 18 years of age for its vacc
New Delhi [India], June 3 (ANI): The Drug Controller of Delhi on Thursday informed the Delhi High Court that Gautam Gambhir Foundation has committed an offence under the Drugs and Cosmetics Act for hoarding unauthorised stock of COVID-19 drugs.
Visakhapatnam (Andhra Pradesh) [India], June 3 (ANI): Refuting allegations that Remdesivir injections, which were expired in March 2021, were administered to patients in Area Hospital, Narsipatnam, the District Drug Control has informed that Drugs Control General of India (DCGI) had given pe